IPP Bureau
NHA releases consultation paper on Operationalising Unified Health Interface
By IPP Bureau - December 16, 2022
UHI is envisioned as a foundational layer of the Ayushman Bharat Digital Mission and aims to enable interoperability in health services in India through open protocols
Synchron raises $75 mn Series C Led by ARCH Venture Partners
By IPP Bureau - December 16, 2022
Gates Frontier, Bezos Expeditions, Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X join ARCH as new additional investors
Mandaviya asserts govt's commitment towards improving access to quality medical education
By IPP Bureau - December 16, 2022
India now has 648 medical colleges in 2022 with a whopping 96% increase in the number of Government Medical Colleges (GMC) alone and a 42% increase in the private sector, since 2014
China aims to lead next bio revolution in advanced biologics, says GlobalData
By IPP Bureau - December 15, 2022
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
Takeda launches CINRYZE in India for hereditary angioedema patients
By IPP Bureau - December 15, 2022
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
ELIX Polymers and Ayudame3D to produce prostheses using recovered ABS
By IPP Bureau - December 15, 2022
Ayúdame3D has become a leading social entity in social technology.
Biocon initiates clinical study of Itolizumab for ulcerative colitis in India
By IPP Bureau - December 15, 2022
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
Torrent enters into co-marketing partnership with Boehringer Ingelheim India
By IPP Bureau - December 15, 2022
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
Briefs: Jubilant Pharmova and Apollo Hospitals Enterprise
By IPP Bureau - December 15, 2022
The company will submit an action plan on the observations and will engage with US FDA for next steps.
Kerala Ayurveda receives US patent for its herbal formulation
By IPP Bureau - December 15, 2022
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
LG Chem inks deal with Innovent Biologics for gout treatment candidate
By IPP Bureau - December 15, 2022
LG Chem will receive totaling up to $95.5 million for the China rights
Seeq achieves AWS Life Sciences Competency status
By IPP Bureau - December 15, 2022
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
De Nora and Aclarity sign agreement to deploy PFAS destroying technology
By IPP Bureau - December 15, 2022
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Hovione and GEA collaborate to advance continuous tableting
By IPP Bureau - December 15, 2022
This partnership stemmed from a successful customer-supplier relationship spanning several years.
Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility
By IPP Bureau - December 14, 2022
The investment will enable the company to enter European markets as well as enhance margins in current markets
